12.04.2017 Views

Sigara Bırakma Tanı ve Tedavi Uzlaşı Raporu (2014)

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Özel Durumlarda <strong>Sigara</strong> <strong>Bırakma</strong><br />

24. ASPECT Consortium: Tobacco or health<br />

in the European Union. Belgien: European<br />

Commission 2004; 1–295.<br />

25. Doll R, Peto R, Boreham J, Sutherland I: Mortality<br />

in relation to smoking: 50 years’ observations<br />

on male British doctors. Bmj 2004; 328: 1519.<br />

26. Connett JE, Murray RP, Buist AS, et al. Changes<br />

in smoking status affect women more than men:<br />

results of the lung health study. Am J Epidemiol<br />

2003; 157: 973–979.<br />

27. Kanner RE, Connett JE, Williams DE, et al.<br />

Effects of randomized assignment to a smoking<br />

cessation inter<strong>ve</strong>ntion and changes in smoking<br />

habits on respiratory symptoms in smokers with<br />

early chronic obstructi<strong>ve</strong> pulmonary disease:<br />

the lung health study. Am J Med 1999; 106:<br />

410–416.<br />

28. Scanlon PD, Connett JE, Waller LA, et al.<br />

Smoking cessation and lung function in mildto-moderate<br />

chronic obstructi<strong>ve</strong> pulmonary<br />

disease. The lung health study. Am J Respir Crit<br />

Care Med 2000; 161: 381–390.<br />

29. Makris D, Moschandreas J, Damianaki A, et<br />

al. Exacerbations and lung function decline in<br />

COPD: new insights in current and exsmokers.<br />

Respir Med 2007; 101: 1305–1312.<br />

30. Shahab L, Jarvis MJ, Britton J,West R: Prevalence,<br />

diagnosis and relation to tobacco dependence<br />

of chronic obstructi<strong>ve</strong> pulmonary disease in a<br />

nationally representati<strong>ve</strong> population sample.<br />

Thorax 2006; 61: 1043–7.<br />

31. Andreas S, Hering T, Mühlig S, Nowak D,<br />

Raupach T, Worth H: Smoking Cessation in<br />

Chronic Obstructi<strong>ve</strong> Pulmonary Disease. Dtsch<br />

Arztebl Int 2009; 106(16): 276–82.<br />

32. Wagena EJ, Zeegers MP, van Schayck<br />

CP,Wouters EF: Benefits and risks of<br />

pharmacological smoking cessation therapies<br />

in chronic obstructi<strong>ve</strong> pulmonary disease. Drug<br />

Saf 2003; 26: 381–403.<br />

33. van der Meer RM,Wagena EJ, Ostelo RW,<br />

Jacobs JE et al.: Smoking cessation for chronic<br />

obstructi<strong>ve</strong> pulmonary disease. Cochrane<br />

Database Syst Rev 2003: CD002999.<br />

34. Wagena EJ, van der Meer RM, Ostelo RJ, Jacobs<br />

JE et al.: The efficacy of smoking cessation<br />

strategies in people with chronic obstructi<strong>ve</strong><br />

pulmonary disease: results from a systematic<br />

review. Respir Med 2004; 98: 805–15.<br />

35. Hughes J, Stead L, Lancaster T: Antidepressants<br />

for smoking cessation. Cochrane Database Syst<br />

Rev 2004: CD000031.<br />

36. Patel K, Schlundt D, Larson C, Wang H,<br />

Brown A, Hargrea<strong>ve</strong>s M: Chronic illness and<br />

smoking cessation. Nicotine Tob Res. 2009<br />

Aug;11(8):933-9.<br />

37. Reichert J, Araújo AJ, Gonçal<strong>ve</strong>s CM, Godoy<br />

I, Chatkin JM, Sales MP, Santos SR; Smoking<br />

cessation guidelines. J Bras Pneumol.<br />

2008;34(10):845-880.<br />

51

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!